Strategic and operational marketing responsibility for the leading flu vaccine Influvac.Close cooperation with the international interdisciplinary teamsDevelopment of new integrated HCP and lay campaignsCoordination of mutlichannel campaigns together with the digital teams

Strategic medical consulting and brand building for Rx companies and brandsNew business and business developmentAnalysis of the customer journey of physicians in telemedicine via market research. Development of B2B communiaction strategy for telemedicine market leader.Design of a brand strategy for B2B and B2C communication in the field of medical cannabis.Group account management Trenfya (psoriasis)Strategy consulting for embecta (diabetes management)Concept and development of a digital platform especially for women with type I diabetes: www.sugar-eves.de

Founder and owner of a healthcare agencyStrategic medical consulting and brand building for medical cannabis companies and brandsDevelopment of an HCP training concept and implementation of training coursesPlanning and hosting of advisory boardsPlanning of an non-interventional study

Leadership of a consultant and medical team (+30)Business development and new business. Significant acquisition of new customers. (+4 Mill Euro)Strategic consulting and brand building for Rx and OTC products. Selection: Lixiana®(prevention of stroke and systemic embolism), Sincronium® (first polypill in german market/Vascular indications), Votum® (Hypertension), Jinarc® (cystic kidney), Epoetin alpha Hexal (Haem/Oncology), Filgrastim®(Haem/Oncology), Medical cannabis, Fosrenol®(CKD)Stakeholder and KOL mapping, customer segmentation, identification of suitable CRMs and providers for target group selection in the area of medical cannabis;Planning and hosting of advisory boards (e. g. antikoagulation, Lixiana)

Strategic consulting and brand building for Rx and OTC products.Leadership of a marketing and medical team.

Strategic and operational marketing responsibility for the leading rheumatoid arthritis drug Cimzia.Strategic and operational preparation of a new indication PSO.Development of a patient support programme.Implementation and management of a CRM system

Leadership of a marketing and medical team.Responsibility for a portfolio with € 140m annual sales, significant gains in market share in highly competitive environmentTarget group-specific approach to diabetologists.Establishment of a hypertension drug in the area of diabetes and diabetic retiniopathy.Development of a strategy to market the data of an endpoint study in an off-label indication to a new target group, ophthalmologists.

Strategic and operational marketing responsibility for Blopress (Hypertension, Nephroprotection metabolic syndrome)

Strategic and operational marketing for the leading Parkinson's Disease medicationsDevelopment of patient support programm "therapy initiative parkinson"Strategic and operational preparation of new indicaion restless legs syndrome. Stakeholder mapping and customer segmentation.Close cooperation with patient associations and key opinion leaders.

Strategic and operational marketing responsibility for Encepur (Tick-Borne Encephalitis Vaccines) and travel vaccines. Launch mangement Encepur adult and Encepur children. Opinion Leader Management.

Selling Fosamax, Vioxx, Zocor, Cozaar to hospital and private-practice customers.Regional new product management, pre-launch and launch planning for Maxalt and Fosamax once weekly.